{"pk":43890,"title":"Toxicity of Bevacizumab (bev): The First in Class Anti-Angiogenesis Agent in Oncology","subtitle":null,"abstract":"","language":"eng","license":{"name":"","short_name":"","text":null,"url":""},"keywords":[{"word":"Clinical Vignette"}],"section":"Article","is_remote":true,"remote_url":"https://escholarship.org/uc/item/6jb2t5b6","frozenauthors":[{"first_name":"Alexander","middle_name":"C","last_name":"Black","name_suffix":"MD","institution":"University of California, Los Angeles","department":"Medicine"}],"date_submitted":null,"date_accepted":null,"date_published":"2012-11-11T15:48:30-08:00","render_galley":null,"galleys":[{"label":"PDF","type":"pdf","path":"https://journalpub.escholarship.org/ucladom_proceedings/article/43890/galley/32693/download/"}]}